AAPG Stock Analysis: Buy, Sell, or Hold?
AAPG - Ascentage Pharma Group International American Depository Shares
$15.37
-0.54 (-3.36%)
▼
5d:
+3.43%
30d:
-8.6%
90d:
-16.95%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Aug 19, 2026
0d
Get Alerted When AAPG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AAPG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AAPG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AAPG is currently trading at $15.37, which is considered slightly low relative to its 30-day fair value range of $15.28 to $17.31.
Technical Outlook: Technically, AAPG is in a strong downtrend. Immediate support is located at $14.54, while resistance sits at $16.50. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: AAPG scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $47.12 (+206.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AAPG is in a strong downtrend. Immediate support is located at $14.54, while resistance sits at $16.50. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: AAPG scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $47.12 (+206.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$15.28 -
$17.31
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 206.7% below Wall St target ($47.12)
- CAUTION: Bottoming setup, but lagging the sector by 26% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$15.28 -
$17.31
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$14.55
Resistance Level
$16.50
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.82
Wall Street Target
$47.13
(+206.7%)
Revenue Growth (YoY)
29.3%
Profit Margin
-228.5%
Share & Embed Analysis
Last updated: October 04, 2026 5:27 PM ET
Data refreshes hourly during market hours. Next update: 6:27 PM
Data refreshes hourly during market hours. Next update: 6:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AAPG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$109 | 76 BUY |
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
27 analysts |
$92 | 46 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 68 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$128 | 56 HOLD |
